Skip to main content
. Author manuscript; available in PMC: 2023 Jan 5.
Published in final edited form as: Cancer Prev Res (Phila). 2022 Jul 5;15(7):447–454. doi: 10.1158/1940-6207.CAPR-22-0011

Figure 2 -. Cumulative incidence of colorectal cancer by aspirin treatment and PRS groups.

Figure 2 -

Competing risks (death from other causes) plots showing cumulative incidence of colorectal cancer for low, medium and high PRS risk groups, with each plot stratified by treatment arm (aspirin/placebo).